Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H15NO |
| Molecular Weight | 237.2964 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)C1C2=CC=CC=C2CCC3=CC=CC=C13
InChI
InChIKey=APBVLLORZMAWKI-UHFFFAOYSA-N
InChI=1S/C16H15NO/c17-16(18)15-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)15/h1-8,15H,9-10H2,(H2,17,18)
| Molecular Formula | C16H15NO |
| Molecular Weight | 237.2964 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cyheptamide is anticonvulsant compound, developed by the Canadian company Ayerst Research Laboratories in the 1960s. Oral administration of compound at 14-25 mg/kg protected mice against the tonic phase of pentylenetetrazole convulsion and maximal electroshock seizure. Anticonvulsant activity of cyheptamide was confirmed in initial clinical studies, but the compound was not marketed.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cytenamide-formic acid (1/1). | 2008-07-05 |
|
| Cytenamide-1,4-dioxane (2/1). | 2008-06-28 |
|
| Cytenamide-butyric acid (1/1). | 2008-06-19 |
|
| Cytenamide trifluoro-acetic acid solvate. | 2008-06-07 |
|
| Cytenamide acetic acid solvate. | 2008-05-30 |
|
| Development and validation of a LC/MS/MS method for simultaneous quantification of oxcarbazepine and its main metabolites in human serum. | 2007-12-15 |
|
| ANTICONVULSANTS. I. DIBENZO(A,D)CYCLOHEPTADIENE-5-CARBOXAMIDE AND RELATED COMPOUNDS. | 1964-01 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:36:03 GMT 2025
by
admin
on
Mon Mar 31 17:36:03 GMT 2025
|
| Record UNII |
6R22P8K61P
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Mon Mar 31 17:36:03 GMT 2025 , Edited by admin on Mon Mar 31 17:36:03 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB06868MIG
Created by
admin on Mon Mar 31 17:36:03 GMT 2025 , Edited by admin on Mon Mar 31 17:36:03 GMT 2025
|
PRIMARY | |||
|
6R22P8K61P
Created by
admin on Mon Mar 31 17:36:03 GMT 2025 , Edited by admin on Mon Mar 31 17:36:03 GMT 2025
|
PRIMARY | |||
|
230-570-8
Created by
admin on Mon Mar 31 17:36:03 GMT 2025 , Edited by admin on Mon Mar 31 17:36:03 GMT 2025
|
PRIMARY | |||
|
C81469
Created by
admin on Mon Mar 31 17:36:03 GMT 2025 , Edited by admin on Mon Mar 31 17:36:03 GMT 2025
|
PRIMARY | |||
|
7199-29-3
Created by
admin on Mon Mar 31 17:36:03 GMT 2025 , Edited by admin on Mon Mar 31 17:36:03 GMT 2025
|
PRIMARY | |||
|
CHEMBL1868301
Created by
admin on Mon Mar 31 17:36:03 GMT 2025 , Edited by admin on Mon Mar 31 17:36:03 GMT 2025
|
PRIMARY | |||
|
m1100
Created by
admin on Mon Mar 31 17:36:03 GMT 2025 , Edited by admin on Mon Mar 31 17:36:03 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000083759
Created by
admin on Mon Mar 31 17:36:03 GMT 2025 , Edited by admin on Mon Mar 31 17:36:03 GMT 2025
|
PRIMARY | |||
|
23603
Created by
admin on Mon Mar 31 17:36:03 GMT 2025 , Edited by admin on Mon Mar 31 17:36:03 GMT 2025
|
PRIMARY | |||
|
C002556
Created by
admin on Mon Mar 31 17:36:03 GMT 2025 , Edited by admin on Mon Mar 31 17:36:03 GMT 2025
|
PRIMARY | |||
|
2191
Created by
admin on Mon Mar 31 17:36:03 GMT 2025 , Edited by admin on Mon Mar 31 17:36:03 GMT 2025
|
PRIMARY | |||
|
DTXSID6046551
Created by
admin on Mon Mar 31 17:36:03 GMT 2025 , Edited by admin on Mon Mar 31 17:36:03 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
